Ventyx Biosciences Inc

-0.35 (-1.88%)
Earnings Announcements

Ventyx Biosciences Reports Q3 Net Loss Per Share Attributable To Common Shareholders $3.17

Published: 11/17/2021 22:53 GMT
Ventyx Biosciences Inc (VTYX) - Ventyx Biosciences Inc Says Luisa Salter-cid Appointed to Chair of the Scientific Advisory Board.
Ventyx Biosciences Inc - Qtrly Net Loss per Share Attributable to Common Shareholders, Basic and Diluted $3.17.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.26

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.28

More details on our Analysts Page.